Deloitte Consulting Buys Analytics Firm Recombinant Data | GenomeWeb

NEW YORK (GenomeWeb News) – Deloitte Consulting late on Tuesday announced it has acquired Recombinant Data for an undisclosed amount.

Based in Newton, Mass., Recombinant Data provides healthcare IT solutions and research data management and analytics. Its products and services, Deloitte Consulting said, are used to advance personalized medicine, translational research — including genomics, phenomics, and proteomics — and healthcare performance management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.